Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Rigel Pharmaceuticals Inc

RIGL
20,43
0,00 (0,00%)
13 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202522:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/3/202522:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/3/202522:22EDGAR2Form 8-K - Current report
10/3/202513:05PRNUSRigel Appoints Mark W. Frohlich, M.D. to Board of Directors
04/3/202522:14EDGAR2Form 8-K - Current report
04/3/202522:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202522:01PRNUSRigel Reports Fourth Quarter and Full Year 2024 Financial..
25/2/202514:05PRNUSRigel Announces Conference Call and Webcast to Report Fourth..
14/2/202523:18EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/2/202502:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202521:58EDGAR2Form 144 - Report of proposed sale of securities
05/2/202521:43EDGAR2Form 144 - Report of proposed sale of securities
05/2/202521:41EDGAR2Form 144 - Report of proposed sale of securities
05/2/202521:40EDGAR2Form 144 - Report of proposed sale of securities
05/2/202519:23EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
04/2/202522:39EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:30EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:21EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:20EDGAR2Form 144 - Report of proposed sale of securities
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:38EDGAR2Form 144 - Report of proposed sale of securities
22/1/202514:05PRNUSRigel's Fostamatinib Being Studied by National Institute of..
13/1/202514:15EDGAR2Form 8-K - Current report
13/1/202514:05PRNUSRigel Provides Business Update and 2025 Outlook
09/1/202514:05PRNUSRigel Announces R289 Granted Orphan Drug Designation by the..
08/1/202514:05PRNUSRigel to Present at the 43rd Annual J.P. Morgan Healthcare..
03/1/202514:05PRNUSRigel Pharmaceuticals, Inc. Announces Inducement Grants..
09/12/202422:15EDGAR2Form 8-K - Current report
09/12/202418:02PRNUSRigel Highlights Initial Data from Ongoing Phase 1b Study..
02/12/202414:05PRNUSRigel Announces R289 Granted Fast Track Designation by the..
27/11/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202423:18EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202421:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:05PRNUSRigel to Present at the Jefferies London Healthcare..
07/11/202422:22EDGAR2Form 8-K - Current report
07/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:01PRNUSRigel Reports Third Quarter 2024 Financial Results and..
05/11/202415:05PRNUSRigel Announces Six Poster Presentations at the 66th..
31/10/202413:05PRNUSRigel Announces Conference Call and Webcast to Report Third..
24/10/202422:35PRNUSRigel Pharmaceuticals Issues Dear Healthcare Provider Letter..
16/10/202416:00GLOBEOptime Care Expands Partnership with Rigel Pharmaceuticals..
Apertura: Min: Max:
Chiusura: 20,43

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network